Dr. Elif Coşkunçay
Dr Elif Coşkunçay, joined GSK in February 2019 and previously was working as GSK Turkey Country Medical Director* and a member of Turkey Leadership Team has been be appointed as Regional Medical Affairs Lead, COVID Therapeutics, Emerging Markets as of 1st February 2021.
After graduation from Istanbul University Cerrahpaşa School of Medicine in 2000, Elif led local and global medical teams in Abbott, Pfizer, Novo Nordisk and Takeda. Elif holds a MSc on Pharmaceutical Medicine. Prior to joining GSK, Elif was the CMO for Bristol-Myers Squibb for the past 4 years with extended experience in oncology/immune-oncology medical affairs.